21 CFR 522.2063
§ 522.2063 Pyrilamine.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 522.2063, § 522.2063 Pyrilamine, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87527
- Permanent ID
ys:prov:87527@1- SHA-256
4a20c427669192b742f13c9f2c6cba2d8a6245338772bb49ed46deb0d39a1d64
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of solution contains 20 milligrams (mg) of pyrilamine maleate.
(b) Sponsors. See sponsor numbers in § 510.600(c) of this chapter for uses in paragraph (c) of this section.
(1) No. 000061 for use as in paragraph (c)(1)(i), (2), and (3) of this section.
(2) No. 061133 for use as in paragraph (c)(1)(ii), (2), and (3) of this section.
(c) Conditions of use—(1) Amount.
(i) Horses, 40 to 60 mg per 100 pounds (lbs) body weight; foals, 20 mg/100 lbs body weight. Administer by intramuscular, subcutaneous, or intravenous injection. Dosage may be repeated every 6 to 12 hours whenever necessary.
(ii) Horses, 40 to 60 mg/100 lbs body weight; foals, 20 mg/100 lbs body weight. Administer by slow intravenous injection. Dosage may be repeated every 6 to 12 hours if necessary.
(2) Indications for use. It is intended for treating horses in conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.
(3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.